HomePembrolizumab plus Lenvatinib in Patients with Metastatic Renal Cell Carcinoma: Real-World Evidence from the International ARON-1 Study

Pembrolizumab Plus Lenvatinib in Patients with Metastatic Renal Cell Carcinoma: Real-World Evidence from the International ARON-1 Study